This website is for Healthcare professionals in the US only

I certify that I am a healthcare professional in the US.

Yes
No

YOU ARE NOW LEAVING WWW.KORSUVA.COM.

Go back
now approved
now approved

Introducing the FIRST AND ONLY FDA-approved treatment for
moderate to severe pruritus associated with chronic kidney
disease (CKD-aP) in adults undergoing hemodialysis (HD).

Limitation of Use: KORSUVA has not been studied in patients on
peritoneal dialysis and is not recommended for use in this population.

Stay updated on the availability
of KORSUVA

Sign up to receive important information and new developments related to KORSUVA.
(All fields required.)

View Privacy Policy.

By providing your email address, you agree to receive emails from us. You may opt out at any time.
We respect your privacy. We will not share your information with any third parties or outside mailing lists. Read our privacy policy